PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
Shareholding Pattern

Glenmark Pharmaceuticals Limited

Promoter holding in Glenmark Pharmaceuticals Limited has stayed unchanged at 46.65% for the last 8 quarters on record (since Sep 2024).

By quarter

Promoters46.65%
Public53.35%
Promoter shares pledged (latest): 0.00% of promoter holding

Quarter by quarter

QuarterPromotersPublic
Jun '26 46.65%=0.00 53.35%=0.00
Mar '26 46.65%=0.00 53.35%=0.00
Dec '25 46.65%=0.00 53.35%=0.00
Sep '25 46.65%=0.00 53.35%=0.00
Jun '25 46.65%=0.00 53.35%=0.00
Mar '25 46.65%=0.00 53.35%=0.00
Dec '24 46.65%=0.00 53.35%=0.00
Sep '24 46.65%=0.00 53.35%=0.00

Trend

Compared with similar companies

Promoter holding in Glenmark Pharmaceuticals Limited is lower than 70% of companies in the Healthcare sector in India.

CompanyPromoters
Glenmark Pharmaceuticals Limited46.65%
Alkem Laboratories Limited49.70%
Aster DM Quality Care Limited53.72%
Fortis Healthcare Limited31.17%
Biocon Limited44.68%
Abbott India Limited74.99%

Similar-sized companies in the same sector, latest quarter on record.

Questions

What is Glenmark Pharmaceuticals Limited's promoter holding?

Promoters held 46.65% of Glenmark Pharmaceuticals Limited as of 30 Jun 2026, and the public held 53.35%.

Has Glenmark Pharmaceuticals Limited's promoter holding increased?

No, it was unchanged in the quarter to Jun 2026.

Are any promoter shares of Glenmark Pharmaceuticals Limited pledged?

No promoter shares are recorded as pledged.

How has Glenmark Pharmaceuticals Limited's promoter holding changed over the years?

Over a longer period, promoter holding went from 46.63% in Sep 2020 to 46.65% in Jun 2026, up 0.02 points.

How does Glenmark Pharmaceuticals Limited's promoter holding compare with similar companies?

Promoter holding in Glenmark Pharmaceuticals Limited is lower than 70% of companies in the Healthcare sector in India. A higher or lower promoter holding is not good or bad by itself.

From the company's quarterly shareholding filings. "Public" includes institutions (foreign and domestic) and individual investors; a split by investor type is planned. ▲/▼ shows the change from the previous quarter, in percentage points. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.